ニュース
新井研究員、南條元博士研究員の論文が Molecular Cancer Therapeutics誌にacceptされました
Nanjo S*, Arai S*, Wang W, Takeuchi S, Yamada T, Hata A, Katakami N, Okada Y, Yano S.
*: equally contribution
MET copy number gain is associated with gefitinib resistance in leptomeningeal carcinomatosis of EGFR-mutant lung cancer
Molecular Cancer Therapeutics
*: equally contribution
MET copy number gain is associated with gefitinib resistance in leptomeningeal carcinomatosis of EGFR-mutant lung cancer
Molecular Cancer Therapeutics
